Calendar Pfizer, Inc.

Equities

PFE

US7170811035

Real-time Estimate Cboe BZX 12:48:49 2023-09-29 pm EDT Intraday chart for Pfizer, Inc. 5-day change 1st Jan Change
33.08 USD +3.07% +0.97% -35.59%

Chart calendar Pfizer, Inc.

0487f8748d6e4a25776a98.9dggyDaPT0IMcqxLk4IM8WfPQZi_GYE8FhipLNYGLcI.puxRnme_OHd7OZ8j2tF-ngD-Da_oQ9Z-bzXDQYFsZLCSvkWre95-dVYw7Q~e40a430f02eadfedbd92552e67ebb4fa

Upcoming events on Pfizer, Inc.

2023-10-31 06:45 am Q3 2023 Earnings Release
2023-10-31 10:00 am Q3 2023 Earnings Call
2024-01-29 Q4 2023 Earnings Release (Projected)
2024-04-29 Q1 2024 Earnings Release (Projected)
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)

Past events on Pfizer, Inc.

2023-09-26 03:30 pm Cantor Global Healthcare Conference
2023-09-18 06:00 am J.P. Morgan U.S. All Stars Conference
2023-09-11 12:15 pm Morgan Stanley Global Healthcare Conference
2023-09-07 10:30 am Citi BioPharma Conference
2023-09-06 12:45 pm Wells Fargo Healthcare Conference
2023-08-01 10:00 am Q2 2023 Earnings Call
2023-08-01 06:45 am Q2 2023 Earnings Release
2023-07-26 Détachement de
2023-06-13 11:00 am Goldman Sachs Global Healthcare Conference
2023-06-05 12:30 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-04 05:30 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-04 12:30 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY MEETING - ABSTRACT NUMBER
2023-06-04 09:00 am AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 04:00 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 04:00 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 02:15 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 02:15 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 02:15 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 02:15 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER
2023-06-03 02:15 pm AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE - ABSTRACT NUMBER

Past dividends on Pfizer, Inc.

2023-07-26 Quarterly 0.41 USD
2023-05-10 Quarterly 0.41 USD
2023-01-25 Quarterly 0.41 USD
2022-11-02 Quarterly 0.4 USD
2022-07-27 Quarterly 0.4 USD
2022-05-11 Quarterly 0.4 USD
2022-01-26 Quarterly 0.4 USD
2021-11-03 Quarterly 0.39 USD
2021-07-28 Quarterly 0.39 USD
2021-05-05 Quarterly 0.39 USD

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
53 647
53 582
0.12%
51 750
51 807
-0.11%
41 908
48 014
-12.72%
81 288
81 781
-0.6%
100 330
100 373
-0.04%

66 425

EBITDA
Million USD
Released
Forecast
Spread
21 814
21 615
0.92%
21 097
22 824
-7.57%
17 801
21 398
-16.81%
25 426
29 444
-13.65%
42 336
44 773
-5.44%

24 110

EBIT
Million USD
Released
Forecast
Spread
20 042
19 998
0.22%
19 420
19 883
-2.33%
13 024
17 362
-24.99%
20 235
26 662
-24.11%
37 272
40 403
-7.75%

20 989

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
11 885
16 386
-27.47%
17 682
22 426
-21.15%
7 497
13 166
-43.06%
24 311
19 569
24.23%
34 729
39 058
-11.08%

18 522

Net income
Million USD
Released
Forecast
Spread
11 153
14 121
-21.02%
16 273
19 053
-14.59%
9 616
16 066
-40.15%
21 979
22 567
-2.6%
31 372
33 053
-5.09%

15 135

EPS
USD
Released
Forecast
Spread
1,87
2,38
-21.44%
2,87
3,40
-15.62%
1,71
2,82
-39.25%
3,85
3,89
-0.9%
5,47
5,85
-6.45%

2,88

Announcement Date01/29/1901/28/2002/02/2102/08/2201/31/23-

Quarterly results

Fiscal PeriodDecember 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3
Net sales
Millions USD
Released
Forecast
Spread
18 977
18 727
1.33%
24 094
22 810
5.63%
23 838
24 203
-1.51%
25 661
24 734
3.75%
27 742
26 199
5.89%
22 638
21 091
7.33%
24 290
24 393
-0.42%
18 282
16 488
10.88%
12 734
13 398
-4.96%

14 875


19 615


17 154


13 289


16 575

EBITDA
Millions USD
Released
Forecast
Spread
8 243
8 414
-2.04%
9 876
8 725
13.2%
4 403
6 196
-28.93%
11 135
13 710
-18.78%
13 583
12 434
9.25%
10 325
10 332
-0.06%
6 772
7 436
-8.92%
7 857
7 513
4.58%
4 925
4 000
23.13%

4 381


5 772










EBIT
Millions USD
Released
Forecast
Spread
6 746
5 527
22.06%
8 516
6 536
30.29%
3 126
5 610
-44.28%
9 948
9 738
2.16%
12 408
11 055
12.24%
9 142
9 092
0.55%
5 253
6 886
-23.71%
6 370
6 471
-1.56%
3 319
3 634
-8.68%

4 226


5 611


6 486







Earnings before Tax (EBT)
Millions USD
Released
Forecast
Spread









9 050








5 231
7 425
-29.55%







2 207


4 753










Net income
Millions USD
Released
Forecast
Spread
5 563
4 548
22.31%
8 146
3 829
112.74%
3 393
5 046
-32.75%
7 864
8 418
-6.58%
9 906
9 799
1.09%
8 608
7 631
12.8%
4 995
5 667
-11.86%
5 543
4 495
23.31%
2 327



1 975


3 208










EPS
USD
Released
Forecast
Spread
0,98
0,76
29.8%
1,42
1,03
37.86%
0,59
0,74
-20.27%
1,37
1,60
-14.17%
1,73
1,64
5.73%
1,51
1,37
10.21%
0,87
0,69
25.48%
0,97
0,85
14.79%
0,41



0,35


0,57










Announcement Date28/07/2102/11/2108/02/2203/05/2228/07/2201/11/2231/01/2302/05/2301/08/23-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer